| 中文名称: | (-)2,2''-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑 |
| 中文别名: | (-)-2,2'-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑;(-)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚并[1,2-d]噁唑;(-)2,2''-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)-2,2`-亚甲基双[(3aS,8aR)-3α,8α-二氢-8H-茚并[1,2-d]噁];(-)-2,2-亚甲基双(3α,8α-二氢-8H-茚并[1,2-d]噁唑;(-)2,2''-亚甲基双(3α,8α-二氢-8H-茚并[1,2-d]恶唑;(-)-2,2-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚并[1,2-d]恶唑];(3aS,3′aS,8aR,8′aR)-(-)-2,2''-亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];[3aS-[2(3 aR*,8 aS*),3 aα,8 aα]]-(-)-2,2 -亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];2-氨基-5-(4-甲氧基)-1,3,4-噁二唑;苯丙氨酸苄酯对甲苯磺酸盐;(-)2,2′-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)2,2'-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)-2,2'-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-吲哚[1,2-d]恶唑];(-)-2,2''-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑;(-)-2,2'-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑];[3aS-[2(3′aR*,8′aS*),3′aα,8′aα]]-(-)-2,2′-亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];(3aS,3'aS,8aR,8'aR)-2,2'-甲桥双[3a,8a-二氢-8H-茚并[1,2-d]恶唑;(-)-2,2'-亚甲基双(3Α,8Α-二氢-8H-茚并[1,2-D]唑;(-)-2,2-亚甲基双[(3AS,8AR)-3Α,8Α-二氢-8H-茚并[1,2-D]噁];(3AS,3′AS,8AR,8′AR)-(-)-2,2'-亚甲基双[3A,8A-二氢-8H-茚并[1,2-D]噁唑];(-)2,2′-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)2,2''-亚甲基双(3Α,8Α-二氢-8H-茚并[1,2--D]噁唑;(-)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚并[1,2-D]噁唑;(-)-2,2-亚甲基双[(3AS,8AR)-3A,8A-二氢-8H-茚并[1,2-D]恶唑];(-)-2,2'-亚甲基双[(3AS,8AR)-3A,8A-二氢-8H-茚苯[1,2-D]并恶唑;(-)-2,2'-亚甲基双[(3AS,8AR)-3A,8A-二氢-8H-吲哚[1,2-D]恶唑];(3AS,3'AS,8AR,8'AR)-2,2'-甲桥双[3A,8A-二氢-8H-茚并[1,2-D]恶唑 |
| smiles: | [H][C@@]12N=C(CC3=N[C@]4([H])[C@](CC5=C4C=CC=C5)([H])O3)O[C@]1([H])CC6=C2C=CC=C6 |
| 英文名称: | [3aS-[2(3'aR*,8'aS*),3'aα,8'aα]]-(-)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] |
| 英文别名: | Bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)methane;(-)-2,2'-Methylenebis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole];[3aS-[2(3'aR*,8'aS*),3'aα,8'aα]]-(-)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];(-)-2,2-Methylenebis(3A,8A-Dihydro-8H-Indeno(1,2-D)Oxazole);(3aS,3'aS,8aR,8'aR)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];8H-Indeno[1,2-d]oxazole,2,2'-methylenebis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-;(3aR,8bS)-2-[[(3aR,8bS)-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazol-2-yl]methyl]-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazole;[3aS-[2(3′aR*,8′aS*),3′aα,8′aα]]-(−)-2,2′-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];(-)-2,2'-Methylenebis;[3aS-[2(3′aR*,8′aS*),3′aα,8′aα]]-(−Bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)methane;[3as-[2(3′Ar*,8′As*),3′AΑ,8′AΑ]]-()-2,2′-Methylenebis[3a,8a-Dihydro-8H-Inden;(3aS,3′aS,8aR,8′aR)-(-)-2,2′-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];(-)-2,2'-METHYLENEBIS(3A,8A-DIHYDRO-8H-I NDENO(1,2-D)OXAZOLE), 98%;(-)-2,2'-Methylenebis[(3AS,8AR)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole],98%;(-)-2,2'-METHYLENEBIS[(3AS,8AR)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE];8H-Indeno[1,2-d]oxazole,2,2'-Methylenebis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-;[3as-[2(3'ar*,8'as*),3'aα,8'aα]]-(-)-2,2'-methylenebis[3a,8a-dihydro-8h-indeno[1,2-d]oxazole];8H-Indeno[1,2-d]oxazole, 2,2'-methylenebis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-;T71934;[3aS-[2(3'aR*,8'aS*),3'a;DTXSID10452334;(-)-2,2/'-METHYLENEBIS[(3AS,8AR)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE];J-011072;bis((3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazol-2-yl)methane;A]]-(-)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];BP-12947;[3aR-[2(3'aR,8'aS),3'a beta ,8'a beta ]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-]oxazole];(3aS,8aR,3a'S,8a'R)-2,2'-Methylenebis(8,8a-dihydro-3aH-indeno[1,2-d][1,3]oxazole);(3aS,3'aS,8aR,8'aR)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 98%;[3AS-[2(3'AR*,8'AS*),3'AALPHA,8'AALPHA]]-(-)-2,2'-METHYLENEBIS[3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE];A881622;(-)-2,2'-Methylenebis[(3aS,8aR)-3a,8a-dihydro-8Hindeno[;A,8'a;AKOS015838880;175166-49-1;AKOS015904445;AS-73642;[3aS-[2(3'aR*,8'aS*),3'a alpha ,8'a alpha ]]-(-)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];CS-W009418;SCHEMBL15248779;(3aS,8aR)-2-{[(3aS,8aR)-3aH,8H,8aH-indeno[1,2-d][1,3]oxazol-2-yl]methyl}-3aH,8H,8aH-indeno[1,2-d][1,3]oxazole;MFCD00799561 |
| CAS号: | 175166-49-1 |
| 分子式: | C21H18N2O2 |
| 分子量: | 330.38 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
(-)2,2''-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑
英文名:
[3aS-[2(3'aR*,8'aS*),3'aα,8'aα]]-(-)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
别名:(-)-2,2'-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑;(-)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚并[1,2-d]噁唑;(-)2,2''-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)-2,2`-亚甲基双[(3aS,8aR)-3α,8α-二氢-8H-茚并[1,2-d]噁];(-)-2,2-亚甲基双(3α,8α-二氢-8H-茚并[1,2-d]噁唑;(-)2,2''-亚甲基双(3α,8α-二氢-8H-茚并[1,2-d]恶唑;(-)-2,2-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚并[1,2-d]恶唑];(3aS,3′aS,8aR,8′aR)-(-)-2,2''-亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];[3aS-[2(3 aR*,8 aS*),3 aα,8 aα]]-(-)-2,2 -亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];2-氨基-5-(4-甲氧基)-1,3,4-噁二唑;苯丙氨酸苄酯对甲苯磺酸盐;(-)2,2′-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)2,2'-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)-2,2'-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-吲哚[1,2-d]恶唑];(-)-2,2''-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑;(-)-2,2'-亚甲基双[(3aS,8aR)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑];[3aS-[2(3′aR*,8′aS*),3′aα,8′aα]]-(-)-2,2′-亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];(3aS,3'aS,8aR,8'aR)-2,2'-甲桥双[3a,8a-二氢-8H-茚并[1,2-d]恶唑;(-)-2,2'-亚甲基双(3Α,8Α-二氢-8H-茚并[1,2-D]唑;(-)-2,2-亚甲基双[(3AS,8AR)-3Α,8Α-二氢-8H-茚并[1,2-D]噁];(3AS,3′AS,8AR,8′AR)-(-)-2,2'-亚甲基双[3A,8A-二氢-8H-茚并[1,2-D]噁唑];(-)2,2′-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(-)2,2''-亚甲基双(3Α,8Α-二氢-8H-茚并[1,2--D]噁唑;(-)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚并[1,2-D]噁唑;(-)-2,2-亚甲基双[(3AS,8AR)-3A,8A-二氢-8H-茚并[1,2-D]恶唑];(-)-2,2'-亚甲基双[(3AS,8AR)-3A,8A-二氢-8H-茚苯[1,2-D]并恶唑;(-)-2,2'-亚甲基双[(3AS,8AR)-3A,8A-二氢-8H-吲哚[1,2-D]恶唑];(3AS,3'AS,8AR,8'AR)-2,2'-甲桥双[3A,8A-二氢-8H-茚并[1,2-D]恶唑
商品编号:R007506-250mg
规格:250mg
纯度:98%
CAS号: 175166-49-1
分子式:C21H18N2O2
分子量:330.38
| 价格 |
¥ 68.00
(请 登录 会员查看折扣价)
|
| 货期 | 现货 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















